Trial intelligence / Profile preview

Oral CBD and THC for Essential Tremor

NCT03805750Phase 2Completed

Sponsor
University of California, San Diego
Start
Jan 2019
Primary completion
Sep 2020
Modality
Autologous CAR-T
Countries
1
01

Overview

A Phase 2 trial of CT120 in essential tremor (ET), sponsored by University of California, San Diego. Started Jan 2019; status: completed.

02

Drugs

CT120
03

Conditions

essential tremor (ET)

Beyond the preview

Go deeper on NCT03805750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03805750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call